CYSLTR1 and myeloid sarcoma: The CysLTR1 and CysLTR2 are upregulated in immune tissues, in serum, in cerebrospinal fluid (CSF), and in CNS tissue of EAE mice following disease onset and in MS patients (Wang et al., 2011; Han et al., 2021).